SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-015387
Filing Date
2019-08-12
Accepted
2019-08-12 17:53:55
Documents
2
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1639
2 EXHIBIT 24.1 f3080819williamsex24-1_neo.htm EX-24.1 5773
  Complete submission text file 0001213900-19-015387.txt   9002
Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Williams Lewis T (Reporting) CIK: 0001475714 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36327 | Film No.: 191017778